Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cadrenal Therapeutics Inc...

    NASDAQ: CVKD · Real-Time Price · USD
    14.68
    -0.81 (-5.23%)
    At close: Jun 05, 2025, 3:59 PM
    15.18
    3.41%
    After-hours: Jun 05, 2025, 07:16 PM EDT

    Cadrenal Therapeutics Common Stock Statistics

    Share Statistics

    Cadrenal Therapeutics Common Stock has 1.97M shares outstanding. The number of shares has increased by -88.26% in one year.

    Shares Outstanding

    n/a
    		 1.97M

    Shares Change (YoY)

    n/a
    		 -88.26%

    Shares Change (QoQ)

    n/a
    		 5.45%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 2,569

    FTD / Avg. Volume

    n/a
    		 10.27%

    Short Selling Information

    The latest short interest is 51.44K, so 2.62% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 51.44K

    Short % of Shares Out

    n/a
    		 2.62%

    Short % of Float

    n/a
    		 3.5%

    Short Ratio (days to cover)

    n/a
    		 1.72

    Valuation Ratios

    The PE ratio is -1.66 and the forward PE ratio is -4.56. Cadrenal Therapeutics Common Stock's PEG ratio is 0.18.

    PE Ratio

    n/a
    		 -1.66

    Forward PE

    n/a
    		 -4.56

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 2.38

    P/FCF Ratio

    n/a
    		 -2.4

    PEG Ratio

    n/a
    		 0.18
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Cadrenal Therapeutics Common Stock.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.77, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 3.77

    Quick Ratio

    n/a
    		 3.77

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,662,842

    Employee Count

    n/a
    		 4

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 95.42% in the last 52 weeks. The beta is 1.12, so Cadrenal Therapeutics Common Stock's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.12

    52-Week Price Change

    n/a
    		 95.42%

    50-Day Moving Average

    n/a
    		 15.83

    200-Day Moving Average

    n/a
    		 15.09

    Relative Strength Index (RSI)

    n/a
    		 53.61

    Average Volume (20 Days)

    n/a
    		 25,003

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -10.96M

    Net Income

    n/a
    		 -10.65M

    EBITDA

    n/a
    		 -10.65M

    EBIT

    n/a
    		 -10.65M

    Earnings Per Share (EPS)

    n/a
    		 -8.73
    Full Income Statement

    Balance Sheet

    The company has 10.02M in cash and 0 in debt, giving a net cash position of 10.02M.

    Cash & Cash Equivalents

    n/a
    		 10.02M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -25.72M

    Total Assets

    n/a
    		 7.95M

    Working Capital

    n/a
    		 6.1M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -7.36M and capital expenditures -6.54K, giving a free cash flow of -7.36M.

    Operating Cash Flow

    n/a
    		 -7.36M

    Capital Expenditures

    n/a
    		 -6.54K

    Free Cash Flow

    n/a
    		 -7.36M

    FCF Per Share

    n/a
    		 -6.04
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    CVKD does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CVKD is $32, which is 114% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $32

    Price Target Difference

    n/a
    		 114%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 20, 2024. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Aug 20, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -0.73

    Piotroski F-Score

    n/a
    		 0

    Add to Watchlist